Cargando…

Natural Autoantibodies in Chronic Pulmonary Diseases

In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Kiyoharu, Tsujino, Kazuyuki, Futami, Shinji, Kida, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037933/
https://www.ncbi.nlm.nih.gov/pubmed/32046322
http://dx.doi.org/10.3390/ijms21031138
_version_ 1783500537691373568
author Fukushima, Kiyoharu
Tsujino, Kazuyuki
Futami, Shinji
Kida, Hiroshi
author_facet Fukushima, Kiyoharu
Tsujino, Kazuyuki
Futami, Shinji
Kida, Hiroshi
author_sort Fukushima, Kiyoharu
collection PubMed
description In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies that are maintained for a long time. Because most of these natural autoantibodies target intracellular proteins or long non-coding RNAs, they are speculated to be non-pathological and have some important as yet unrecognized physiological functions such as debris clearance. Recently, we revealed a set of disease-specific natural autoantibodies of chronic pulmonary diseases with unknown etiology by protein arrays that enable detection of specific autoantibodies against >8000 targets. Surprisingly, some of the targeted antigens of disease-specific autoantibodies were subsequently reported by other laboratories as strongly associated with the disease, suggesting that these antigens reflect the pathology of each disease. Furthermore, some of these autoantibodies that target extracellular antigens might modify the original course of each disease. Here, we review the disease-specific natural autoantibodies of chronic pulmonary diseases, including chronic fibrosing idiopathic interstitial pneumonias, sarcoidosis, and autoimmune pulmonary alveolar proteinosis, and discuss their utility and effects.
format Online
Article
Text
id pubmed-7037933
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70379332020-03-10 Natural Autoantibodies in Chronic Pulmonary Diseases Fukushima, Kiyoharu Tsujino, Kazuyuki Futami, Shinji Kida, Hiroshi Int J Mol Sci Review In autoantibody-mediated autoimmune diseases, pathogenic autoantibodies generated by a failure of central or peripheral tolerance, have different effects mediated by a variety of mechanisms. Interestingly, even non-autoimmune chronic diseases have a set of disease-specific natural autoantibodies that are maintained for a long time. Because most of these natural autoantibodies target intracellular proteins or long non-coding RNAs, they are speculated to be non-pathological and have some important as yet unrecognized physiological functions such as debris clearance. Recently, we revealed a set of disease-specific natural autoantibodies of chronic pulmonary diseases with unknown etiology by protein arrays that enable detection of specific autoantibodies against >8000 targets. Surprisingly, some of the targeted antigens of disease-specific autoantibodies were subsequently reported by other laboratories as strongly associated with the disease, suggesting that these antigens reflect the pathology of each disease. Furthermore, some of these autoantibodies that target extracellular antigens might modify the original course of each disease. Here, we review the disease-specific natural autoantibodies of chronic pulmonary diseases, including chronic fibrosing idiopathic interstitial pneumonias, sarcoidosis, and autoimmune pulmonary alveolar proteinosis, and discuss their utility and effects. MDPI 2020-02-08 /pmc/articles/PMC7037933/ /pubmed/32046322 http://dx.doi.org/10.3390/ijms21031138 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fukushima, Kiyoharu
Tsujino, Kazuyuki
Futami, Shinji
Kida, Hiroshi
Natural Autoantibodies in Chronic Pulmonary Diseases
title Natural Autoantibodies in Chronic Pulmonary Diseases
title_full Natural Autoantibodies in Chronic Pulmonary Diseases
title_fullStr Natural Autoantibodies in Chronic Pulmonary Diseases
title_full_unstemmed Natural Autoantibodies in Chronic Pulmonary Diseases
title_short Natural Autoantibodies in Chronic Pulmonary Diseases
title_sort natural autoantibodies in chronic pulmonary diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037933/
https://www.ncbi.nlm.nih.gov/pubmed/32046322
http://dx.doi.org/10.3390/ijms21031138
work_keys_str_mv AT fukushimakiyoharu naturalautoantibodiesinchronicpulmonarydiseases
AT tsujinokazuyuki naturalautoantibodiesinchronicpulmonarydiseases
AT futamishinji naturalautoantibodiesinchronicpulmonarydiseases
AT kidahiroshi naturalautoantibodiesinchronicpulmonarydiseases